General Evaluator, Clinical Trial Patient Experience jobs in United States
cer-icon
Apply on Employer Site
company-logo

Hippocratic AI · 2 weeks ago

General Evaluator, Clinical Trial Patient Experience

Hippocratic AI is the leading generative AI company in healthcare, focused on creating a safe and autonomous clinical conversation system for patients. The General Evaluator, Clinical Trial Patient Experience will review AI-led patient interactions to ensure compliance with protocols and guidelines, requiring hands-on experience in clinical trial recruitment or operations.

Artificial Intelligence (AI)Foundational AIGenerative AIHealth CareInformation Technology
check
Growth Opportunities

Responsibilities

Review and assess patient-facing Voice AI interactions
Listen to and speak with AI-led recruitment and screening calls
Evaluate whether the agent sounds appropriate, follows protocols and regulatory guidelines, and handles patient interactions correctly

Qualification

Clinical trial recruitmentPatient-facing operationsJudgment calls on AITechnical tools experienceWritten communicationVerbal communicationFluency in additional languageAI exposureCall quality reviewFluency in English

Required

2–5+ years of experience in clinical trial recruitment or patient-facing clinical operations (site, CRO, or call-based teams)
Experience engaging with patients or reviewing patient-facing recruitment, screening, or follow-up interactions
Strong written and verbal communication skills
Ability to make clear, accurate judgment calls when evaluating AI performance (tone, accuracy, and protocol adherence)
Fluency in English
Reliable access to a computer and high-speed internet

Preferred

Fluency in an additional language
Experience using technical or software-based tools (e.g., CRMs, CTMS, call review platforms)
Prior exposure to AI, digital health, or call quality review

Company

Hippocratic AI

twittertwittertwitter
company-logo
Hippocratic AI is a healthcare technology company that develops safety-focused large-language models for medical applications.

Funding

Current Stage
Growth Stage
Total Funding
$402M
Key Investors
AvenirKleiner PerkinsNVentures
2025-11-03Series C· $126M
2025-01-09Series B· $141M
2024-09-19Series A· $17M

Leadership Team

leader-logo
Alex Miller
Co-Founder
linkedin
leader-logo
Amy McCarthy
Chief Nursing Officer
linkedin
Company data provided by crunchbase